Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma

SIMPLE SUMMARY: Skeletal muscle volume has been reported as a prognostic factor for patients with hepatocellular carcinoma receiving sorafenib. In this study, we show that skeletal muscle volume is not only a predictor of overall survival but also of post-progression survival, which represents survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, Issei, Yamasaki, Takahiro, Yamauchi, Yurika, Takami, Taro, Kawaoka, Tomokazu, Uchikawa, Shinsuke, Hiramatsu, Akira, Aikata, Hiroshi, Kawano, Reo, Kobayashi, Kazufumi, Kondo, Takayuki, Ogasawara, Sadahisa, Chiba, Tetsuhiro, Chayama, Kazuaki, Kato, Naoya, Sakaida, Isao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124673/
https://www.ncbi.nlm.nih.gov/pubmed/34067075
http://dx.doi.org/10.3390/cancers13092247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124673/
https://www.ncbi.nlm.nih.gov/pubmed/34067075
http://dx.doi.org/10.3390/cancers13092247

Ejemplares similares